Ipsen

This study tested a single injection of triptorelin pamoate that lasts 6 months in 195 Chinese men with advanced or metastatic prostate cancer. The goal was to lower testosterone to castrate levels, which helps control cancer growth. Results showed the injection effectively reduc…

This study tested the drug cabozantinib in 127 adults with advanced kidney cancer that continued to grow after initial immunotherapy. The goal was to see if cabozantinib could shrink tumors or slow the disease. Participants took cabozantinib pills, and doctors measured tumor resp…

This study tested a new combination of chemotherapy drugs (irinotecan liposome, oxaliplatin, 5-FU, and leucovorin) against the current standard treatment (nab-paclitaxel plus gemcitabine) in 770 people with metastatic pancreatic cancer who had not yet received chemotherapy. The g…

This study compared two injectable treatments, Dysport and Botox, for adults with upper limb spasticity (stiffness in the arm muscles). The goal was to see if Dysport is as safe as Botox and whether it provides a longer-lasting effect. 464 adults participated, and each received b…

This study used a small wearable device called the ADAM sensor to track scratching and sleep patterns in 30 adults with primary biliary cholangitis (PBC), a rare liver disease that often causes severe itching and poor sleep. Participants wore the sensor for 7 nights at a time ove…

This study followed 831 men aged 60 and older with prostate cancer who were starting hormone therapy (GnRH agonists). Researchers tracked how their quality of life changed over six months using questionnaires. The goal was to understand how different age groups cope with treatmen…

This study looked at whether a device called GripAble can help monitor how well botulinum toxin injections work for people with arm muscle tightness (spasticity). Sixteen adults who were already scheduled for treatment used the tool at home. The goal was to see if GripAble could …

This study looked at how moderate and severe liver impairment changes the way the body handles a single dose of the drug palovarotene. Researchers compared 31 participants with liver problems to healthy volunteers. The goal was to understand safety and drug levels in the blood, n…